HighTower Advisors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.7K | Hold |
12,150
| – | – | ﹤0.01% | 3564 |
|
2025
Q1 | $17.7K | Hold |
12,150
| – | – | ﹤0.01% | 3460 |
|
2024
Q4 | $25.9K | Sell |
12,150
-17,500
| -59% | -$37.3K | ﹤0.01% | 3437 |
|
2024
Q3 | $82K | Sell |
29,650
-906
| -3% | -$2.51K | ﹤0.01% | 3312 |
|
2024
Q2 | $72K | Hold |
30,556
| – | – | ﹤0.01% | 3217 |
|
2024
Q1 | $137K | Buy |
30,556
+5,000
| +20% | +$22.4K | ﹤0.01% | 3053 |
|
2023
Q4 | $82K | Sell |
25,556
-30,303
| -54% | -$97.2K | ﹤0.01% | 3186 |
|
2023
Q3 | $176K | Sell |
55,859
-468
| -0.8% | -$1.48K | ﹤0.01% | 2935 |
|
2023
Q2 | $279K | Sell |
56,327
-532
| -0.9% | -$2.64K | ﹤0.01% | 2598 |
|
2023
Q1 | $280K | Sell |
56,859
-488
| -0.9% | -$2.4K | ﹤0.01% | 2492 |
|
2022
Q4 | $361K | Sell |
57,347
-10,712
| -16% | -$67.4K | ﹤0.01% | 2323 |
|
2022
Q3 | $734K | Hold |
68,059
| – | – | ﹤0.01% | 1777 |
|
2022
Q2 | $776K | Buy |
68,059
+17,500
| +35% | +$200K | ﹤0.01% | 1779 |
|
2022
Q1 | $462K | Sell |
50,559
-30
| -0.1% | -$274 | ﹤0.01% | 2208 |
|
2021
Q4 | $753K | Sell |
50,589
-1,220
| -2% | -$18.2K | ﹤0.01% | 1908 |
|
2021
Q3 | $1.33M | Buy |
51,809
+5,500
| +12% | +$142K | ﹤0.01% | 1496 |
|
2021
Q2 | $1.21M | Sell |
46,309
-2,000
| -4% | -$52.2K | ﹤0.01% | 1523 |
|
2021
Q1 | $1.7M | Hold |
48,309
| – | – | 0.01% | 1218 |
|
2020
Q4 | $1.22M | Buy |
48,309
+3,850
| +9% | +$97.1K | 0.01% | 1157 |
|
2020
Q3 | $1.68M | Sell |
44,459
-1,826
| -4% | -$68.9K | 0.01% | 952 |
|
2020
Q2 | $1.98M | Sell |
46,285
-10,160
| -18% | -$434K | 0.01% | 805 |
|
2020
Q1 | $1.1M | Buy |
+56,445
| New | +$1.1M | 0.01% | 957 |
|
2019
Q4 | – | Sell |
-23,140
| Closed | -$630K | – | 2171 |
|
2019
Q3 | $630K | Buy |
23,140
+11,738
| +103% | +$320K | ﹤0.01% | 1396 |
|
2019
Q2 | $306K | Buy |
+11,402
| New | +$306K | ﹤0.01% | 1784 |
|